These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 26487555

  • 41. Correlation of HER2 expression with clinicopathological characteristics and prognosis in resectable gastric cancer.
    Otsu H, Oki E, Ikawa-Yoshida A, Kawano H, Ando K, Ida S, Kimura Y, Aishima S, Saeki H, Morita M, Kohnoe S, Oda Y, Maehara Y.
    Anticancer Res; 2015 Apr; 35(4):2441-6. PubMed ID: 25862912
    [Abstract] [Full Text] [Related]

  • 42. Value of apparent diffusion coefficient (ADC) in assessing radiotherapy and chemotherapy success in cervical cancer.
    Fu ZZ, Peng Y, Cao LY, Chen YS, Li K, Fu BH.
    Magn Reson Imaging; 2015 Jun; 33(5):516-24. PubMed ID: 25660642
    [Abstract] [Full Text] [Related]

  • 43. Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier.
    Balluff B, Elsner M, Kowarsch A, Rauser S, Meding S, Schuhmacher C, Feith M, Herrmann K, Röcken C, Schmid RM, Höfler H, Walch A, Ebert MP.
    J Proteome Res; 2010 Dec 03; 9(12):6317-22. PubMed ID: 21058730
    [Abstract] [Full Text] [Related]

  • 44. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
    Qiu M, Zhou Y, Zhang X, Wang Z, Wang F, Shao J, Lu J, Jin Y, Wei X, Zhang D, Wang F, Li Y, Yang D, Xu R.
    BMC Cancer; 2014 Nov 07; 14():823. PubMed ID: 25380654
    [Abstract] [Full Text] [Related]

  • 45. The quantification of HER2 and MYC gene fragments in cell-free plasma as putative biomarkers for gastric cancer diagnosis.
    Park KU, Lee HE, Nam SK, Nam KH, Park DJ, Kim HH, Kim WH, Lee HS.
    Clin Chem Lab Med; 2014 Jul 07; 52(7):1033-40. PubMed ID: 24670359
    [Abstract] [Full Text] [Related]

  • 46. Prognostic Role of Diffusion-weighted MR Imaging for Resectable Gastric Cancer.
    Giganti F, Orsenigo E, Esposito A, Chiari D, Salerno A, Ambrosi A, Albarello L, Mazza E, Staudacher C, Del Maschio A, De Cobelli F.
    Radiology; 2015 Aug 07; 276(2):444-52. PubMed ID: 25816106
    [Abstract] [Full Text] [Related]

  • 47. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N, Ota H, Mugikura S, Takasawa C, Ishida T, Watanabe G, Tada H, Watanabe M, Takase K, Takahashi S.
    Radiology; 2015 Jan 07; 274(1):66-73. PubMed ID: 25203132
    [Abstract] [Full Text] [Related]

  • 48. Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses.
    Ponhold L, Javor D, Heinz-Peer G, Sevcenco S, Hofstetter M, Baltzer PA.
    Acta Radiol; 2016 Aug 07; 57(8):1014-20. PubMed ID: 26486599
    [Abstract] [Full Text] [Related]

  • 49. [Dual-color silver-enhanced in-situ hybridization for determination of HER2 gene amplification in gastric carcinoma].
    Fan D, Li Y, Ran W, Yu W, Li H.
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan 07; 43(1):4-7. PubMed ID: 24713241
    [Abstract] [Full Text] [Related]

  • 50. Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients.
    Hayano K, Miura F, Amano H, Toyota N, Wada K, Kato K, Sano K, Takeshita K, Aoyagi T, Shuto K, Matsubara H, Asano T, Takada T.
    J Hepatobiliary Pancreat Sci; 2013 Feb 07; 20(2):243-8. PubMed ID: 22311389
    [Abstract] [Full Text] [Related]

  • 51. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
    Kagebayashi Y, Nakai Y, Matsumoto Y, Samma S, Miyasaka T, Nakagawa H.
    Hinyokika Kiyo; 2012 Aug 07; 58(8):405-8. PubMed ID: 23052263
    [Abstract] [Full Text] [Related]

  • 52. Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics.
    Lee JS, Kim SH, Im SA, Kim MA, Han JK.
    Korean J Radiol; 2017 Aug 07; 18(5):809-820. PubMed ID: 28860898
    [Abstract] [Full Text] [Related]

  • 53. HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.
    Cruz-Reyes C, Gamboa-Dominguez A.
    Int J Surg Pathol; 2013 Jun 07; 21(3):240-6. PubMed ID: 23564704
    [Abstract] [Full Text] [Related]

  • 54. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
    Yoo MW, Han HS, Kim SY, Cho YH, Lee HG, Kim JH, Bang HY, Lee KY, Yoon SY.
    Hepatogastroenterology; 2014 May 07; 61(131):858-62. PubMed ID: 26176087
    [Abstract] [Full Text] [Related]

  • 55. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
    Fassan M, Pizzi M, Realdon S, Balistreri M, Guzzardo V, Zagonel V, Castoro C, Mastracci L, Farinati F, Nitti D, Zaninotto G, Rugge M.
    Hum Pathol; 2013 Sep 07; 44(9):1804-10. PubMed ID: 23618359
    [Abstract] [Full Text] [Related]

  • 56. Multiparametric MR characterization for human epithelial growth factor receptor 2 expression in bladder cancer: an exploratory study.
    Kong L, Ling J, Cao W, Wen Z, Lin Y, Cai Q, Chen Y, Guo Y, Chen J, Wang H.
    Abdom Radiol (NY); 2024 Jul 07; 49(7):2349-2357. PubMed ID: 38867120
    [Abstract] [Full Text] [Related]

  • 57. Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma.
    Cordts Filho RM, Kassab P, Claro LC, Fracassi MT, Colombo-Souza P, Fukuhara DK, Thuler FR, de Freitas Junior WR, Ilias EJ, Malheiros CA.
    ScientificWorldJournal; 2016 Jul 07; 2016():7951365. PubMed ID: 28105465
    [Abstract] [Full Text] [Related]

  • 58. High Frequency of Juxtamembrane Domain ERBB2 Mutation in Gastric Cancer.
    Park S, Ahn S, Kim DG, Kim H, Kang SY, Kim KM.
    Cancer Genomics Proteomics; 2022 Jul 07; 19(1):105-112. PubMed ID: 34949663
    [Abstract] [Full Text] [Related]

  • 59. Concerns: the role of diffusion-weighted MR imaging and ADC values in the diagnosis of gastric tumors.
    Incedayi M, Sivrioglu AK, Sönmez G.
    JBR-BTR; 2012 Jul 07; 95(5):332; author reply 332-3. PubMed ID: 23198380
    [No Abstract] [Full Text] [Related]

  • 60. Is "liquid biopsy" useful for assessing HER2 status in gastric cancer?
    Shimada H.
    J Gastroenterol; 2015 Jan 07; 50(1):119-20. PubMed ID: 24825793
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.